PseudoBulbar Affect (PBA) is a distressing neurologic condition characterized by sudden and uncontrolled outbursts of laughing and/or crying. Learn how Nuedexta, a new drug in
VIDEO & ARTICLE: Why were people with rheumatoid arthritis getting less Alzheimer’s? Find out how the answer to this question has triggered an anti-Alzheimer’s trial
RESEARCH VIDEO – Alzheimer’s International Conference: See NIH-sponsored research exploring intranasal insulin as a potentially strong treatment for dementia.
The Alzheimer’s drugs on the market today help compensate for the problems caused by Alzheimer’s. However, they do not stop the disease or change its
VIDEO The A4 Study uses the drug solanezumab in one of the most ambitious attempts yet to thwart Alzheimer’s. The major clinical trial got underway
Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to
VIDEO + ARTICLE CERE-110 is a big step forward for Alzheimer’s clinical trials. It induces brain cells to make their own nerve-growth-factor, so they can
VIDEO & ARTICLE: See how doctors implant a deep-brain-stimulation device in “The Advance Study”. Learn how its electrodes stimulate a part of the brain called
VIDEO+ARTICLE Cognoptix announced strong results in a clinical trial of its SAPPHIRE II eye test. It successfully identified Alzheimer’s via the human eye’s beta-amyloid signature.
VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
Teresa Youngstrom is a registered nurse. She offers a quick tip for caregivers, friends and family when visiting or living with someone with dementia to help smooth the way. Watch now.
Australian researchers show nanoparticles that contain curcumin, from turmeric, not only prevent cognitive deterioration, but also reverse the damage. Find out more about this exciting development.
Dr. Rudy Tanzi is Professor of Neurology at Harvard Medical and Director of McCance Center for Brain Health. Based on 3 decades of his research, learn how CogniSHIELD uniquely protects against amyloid, inflammation and Alzheimer’s.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.
